Found: 8
Select item for more details and to access through your institution.
Phase I study of DFP-11207, a novel oral fluoropyrimidine with reasonable AUC and low C<sub>max</sub> and improved tolerability, in patients with solid tumors.
- Published in:
- Investigational New Drugs, 2020, v. 38, n. 6, p. 1763, doi. 10.1007/s10637-020-00939-w
- By:
- Publication type:
- Article
Two phase I, pharmacokinetic, and pharmacodynamic studies of DFP-10917, a novel nucleoside analog with 14-day and 7-day continuous infusion schedules.
- Published in:
- Investigational New Drugs, 2019, v. 37, n. 1, p. 76, doi. 10.1007/s10637-018-0602-0
- By:
- Publication type:
- Article
Phase II study of DFP-10917, a deoxycytidine analog, given by 14-day continuous intravenous infusion for chemotherapy-refractory advanced colorectal cancer.
- Published in:
- Investigational New Drugs, 2018, v. 36, n. 5, p. 895, doi. 10.1007/s10637-018-0615-8
- By:
- Publication type:
- Article
On Brauer's theorem on sections in the theory of blocks of group characters.
- Published in:
- Mathematische Zeitschrift, 1961, v. 75, n. 1, p. 299, doi. 10.1007/BF01211028
- By:
- Publication type:
- Article
Analysis of the prolonged infusion of DFP-10917, a deoxycytidine analog, as a therapeutic strategy for the treatment of human tumor xenografts in vivo.
- Published in:
- International Journal of Oncology, 2018, v. 52, n. 3, p. 851, doi. 10.3892/ijo.2018.4246
- By:
- Publication type:
- Article
Anticancer activity of the intraperitoneal-delivered DFP-I0825, the cationic liposome-conjugated RNAi molecule targeting thymidylate synthase, on peritoneal disseminated ovarian cancer xenograft model.
- Published in:
- Drug Design, Development & Therapy, 2018, v. 12, p. 673, doi. 10.2147/DDDT.S156635
- By:
- Publication type:
- Article
Development of new promising antimetabolite, DFP-11207 with self-controlled toxicity in rodents.
- Published in:
- Drug Design, Development & Therapy, 2017, v. 11, p. 1693, doi. 10.2147/DDDT.S128420
- By:
- Publication type:
- Article
Phase 1/2 study of DFP-10917 administered by continuous intravenous infusion in patients with recurrent or refractory acute myeloid leukemia.
- Published in:
- 2019
- By:
- Publication type:
- journal article